Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 130.63M | $ 11.41M | 8.74% |
3/31/2025 | $ 158.07M | $ 11.76M | 7.44% |
12/31/2024 | $ 245.96M | $ 7.32M | 2.98% |
9/30/2024 | $ 317.44M | $ 1.87M | 0.59% |
6/30/2024 | $ 321.7M | $ 0 | 0% |
3/31/2024 | $ 258.01M | $ 0 | 0% |
12/31/2023 | $ 282.62M | $ 0 | 0% |
9/30/2023 | $ 296.64M | $ 0 | 0% |
6/30/2023 | $ 342.98M | $ 0 | 0% |
3/31/2023 | $ 288.08M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: Inventory [ $ 0 ] / Assets [ $ 479.02M ]
(=) Inv. to Assets [ 0% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.09% |
median | 0% |
std | 11.11% |